5Ukinc K,Ersoz H O,Karahan C,et al.Methyltetrahydrofolate reductase C677T gene mutation and byperhomocysteinemia as a novel risk factor for disbetic nephropathy[J].Endocrine,2009,36(2):255.
3Wollesen F,Bratestroml,Refsum H,et al.plasma tltal honocysteine and cysteine in relation to glomerular fileration rate in diabetes,ellitus[J].Kidney Int,1999,55:1028-1035.
4Wofmann MA,Kohl B,Zumbach MS,et al.Hyperhomocy-steinemia and endothelial dysfunction in IDDM[J].Diabetes Care,1997,20:1880-1886.
5Hoogeveen EK, Kostense PJ, Beks P J, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus:a population-based study. Arterioscler Thromb Vase Biol,1998,18: 133-138.
6Passaro A, D'Elia K, Pareschi PL, et al. Factors influencing plasma homocysteine levels in type 2 diabetes. Diabetes Care,2000,23:420 421.
7Fonseca VA, Mudaliar S, Schmidt B, et al. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism,1998, 47: 686-689.
8Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure, Clin Nephrol, 1993, 40: 230-235.
9Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetesmellhus. KidneyInt, 1999, 55:1028-1035.
10Panganamala RV, Karpen CW, Merola AJ. Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis.Prostaglandins Leukot Med, 1986, 22:349-356.
3Ozmen B,Ozmen D,Turgan N. Assciaton between homocysteinemia and renal function in patients with type 2 diabetes mellitus[J].Annals of Clinical and Laboratory Science,2002,(03):279-286.
4赵家良.北京协和医院医疗诊疗常规--眼科诊疗常规[M]北京:人民卫生出版社,20055.
5Mogensen CE. Early diabetic renal invo wement and nephropathy[A].El Sevier Scienc Publisher,1987.306.
